• Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications.

      Miljković, Nenad; Godman, Brian; Kovačević, Milena; Polidori, Piera; Tzimis, Leonidas; Hoppe-Tichy, Torsten; Saar, Marika; Antofie, Ioan; Horvath, Laszlo; De Rijdt, Thomas; et al. (2020-03-26)
      A semi-structured questionnaire focusing on medicine shortages was distributed electronically to members of the European Cooperation in Science and Technology (COST) Action 15105 (28 member countries) and to hospital pharmacists of the European Association of Hospital Pharmacists (EAHP) (including associated healthcare professionals). Their answers were subjected to both qualitative and quantitative analysis (Microsoft Office Excel 2010 and IBM SPSS Statistics®) with descriptive statistics based on the distribution of responses. Their proportional difference was tested by the chi-square test and Fisher's exact test for independence. Differences in the observed ordinal variables were tested by the Mann-Whitney or Kruskal-Wallis test. The qualitative data were tabulated and recombined with the quantitative data to observe, uncover and interpret meanings and patterns.
    • So you thought they were clean enough?...

      Kaur, Harpreet; Midland Regional Hospital, Tullamore (Midland Regional Hospital, Tullamore, 2012)
      The extensive use of cytotoxic drugs in the treatment of cancer patients represents a health risk for all staff involved in the preparation and handling of such drugs. This qualifies as an occupational health hazard and the two groups with the highest levels of exposure are pharmacists who dispense these drugs and nursing staff who administer them [1]. Equally other staff involved in their compounding, as well as logistical and training personnel are likely to be exposed.